9637 — Alebund Pharmaceuticals (Jiangsu) Balance Sheet
0.000.00%
Last trade - 00:00- HK$6.09bn
- HK$5.13bn
- CNY30.56m
Annual balance sheet for Alebund Pharmaceuticals (Jiangsu), fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Short Term Investments | ||
| Cash and Short Term Investments | 366 | 531 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 14.1 | 0.676 |
| Total Inventory | ||
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 389 | 559 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 632 | 613 |
| Net Intangible Assets | ||
| Long Term Investments | ||
| Long Term Notes Receivable | ||
| Other Long Term Assets | ||
| Total Assets | 1,109 | 1,340 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Current Portion of Long Term Debt / Capital Leases | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 1,944 | 240 |
| Long Term Debt | ||
| Capital Lease Obligations | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Minority Interest | ||
| Total Other Liabilities | ||
| Total Liabilities | 2,440 | 837 |
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Other Equity | ||
| Total Equity | -1,330 | 503 |
| Total Liabilities & Shareholders' Equity | 1,109 | 1,340 |
| Total Common Shares Outstanding |